易损斑块研究进展
被引量:5
Developments of vulnerable plaque
摘要
自1844年学者们首次对动脉粥样硬化破裂斑块的组织学进行描述以来,一些领先的研究者和临床医师进行了大量研究,使当今不稳定的斑块导致斑块破裂的观点得到普遍接受.
出处
《中国心血管病研究》
CAS
2012年第1期63-65,共3页
Chinese Journal of Cardiovascular Research
参考文献19
-
1Finn AV, Nakano M, Narula J, et al. Concept of vulnerable/unstable plaque. Artefiosoler Throrab Vasc Biol,2010,30:1282-1292.
-
2Maintz D. Plaque and differentiation benhanced inversion clinical research. Copyright Oxford Univ, 2006,27 : 1732-1736.
-
3Fishbein MC. The vulnerable and unstable athemsclerotic plaque. C ardiovasc Pathol, 2010,19 : 6-11.
-
4Moreno PR. Vulnerable plaque: definition, diagnosis, and treatment. Cardiol Clin,2010,28:1-30.
-
5Kips JG, Segers P, Van Bortel LM. Identifying the vulnerable plaque: A review of invasive and non-invasive imaging modalities. Artery Research,2008,2:21-34.
-
6Ambrose JA, Srikanth S. Vulnerable plaques and patients: improving prediction of future coronary events. Am J Med, 2010,123 : 10-16.
-
7Hellings WE, Peeters W, Moll FL, et al. From vulnerable plaque to vulnerable patient: the search for biomarkers of plaque destabilization. Trends Cardiovasc Med,2007,17:162-171.
-
8Virmani R, Burke AP, Farb A, et al. Pathology of the vulnerable plaque. J Am Coil Cardiol, 2006,47 : C 13-18.
-
9Valgimigli M, Agostonl P, Serruvs PW. Acute coronary syndromes: an emphasis shift from treatment to prevention; and the enduring challenge of vulnerable plaque detection in the cardiac catheterization laboratory. J Cardiovasc Med (Hagerstown), 2007,8 : 221-229.
-
10Friedewald VE, Ambrose JA, Stone GW, et al. The editor's roundtable: the vulnerable plaque. Am J Cardiol,2008,102: 1644-1653.
二级参考文献20
-
1倪祝华,杨新春,王乐丰,邹阳春,王红石,葛永贵,佟子川.中等程度冠状动脉狭窄的血管内超声特点与治疗决策选择[J].中国介入影像与治疗学,2005,2(1):15-18. 被引量:16
-
2李卫华,滕志涛,吴荣,谢强,郭启军,唐蓉,陈焕章.血管内超声诊断冠脉造影阴性不稳定斑块5例分析[J].中国心血管病研究,2005,3(7):497-498. 被引量:5
-
3程训民,何国祥,仝识非,冉擘力,刘建平,姚青,宋治远.血管内超声显像指标对冠状动脉中度狭窄病变功能意义的判断价值[J].心肺血管病杂志,2005,24(3):132-135. 被引量:15
-
4Kawasaki M,Sano K,Okubo M,et al.Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound.J Am Coll Cardiol,2005,45:1946-1953.
-
5Roy P,Steinberg DH,Sushinsky SJ,et al.The potential clinical utility of intravas -cular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents.Eur Heart J,2008,29:1851-1857.
-
6Park SJ,Kim YH,Park DW,et al.Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis.Circ Cardiovasc Interv,2009,2:167-177.
-
7Aoki J,Nakazawa G,Tanabe K,et al.Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation.Catheter Cardiovasc Interv,2007,69:380-386.
-
8Nicholls SJ,Tuzcu EM,Wolski K,et al.Coronary artery calcification and changes in atheroma burden in response to established medical therapies.J Am Coll Cardiol,2007,49:263-270.
-
9Yasue H,Nakagawa H,Itoh T,et al.Coronary artery spasm-clinical features,diagnosis,pathogenesis,and treatment.J Cardiol,2008,51:2-17.
-
10Stern S,Bayes de Luna A.Coronary artery spasm:a 2009 update.Circulation,2009,119:2531-2534.
共引文献10
-
1王盛宇,赵铁夫,刘东,毛玉琦,陈卫.Enclose无阻断近端吻合系统在老年患者OPCAB术中的应用[J].中国心血管病研究,2011,9(6):426-428. 被引量:2
-
2李永洪,宋道岭.钙拮抗剂合心爽抑制动脉粥样硬化形成的实验研究[J].中国心血管病研究,2011,9(10):775-778.
-
3李红旗,章琦,陈莉,严光,胡立群.吡咯列酮对HDL功能的调节及其抗动脉粥样硬化的机制[J].安徽医药,2013,17(11):1841-1844. 被引量:4
-
4孟泽军,马洪山.冠状动脉病变介入治疗决策的研究进展[J].中西医结合心脑血管病杂志,2015,13(2):203-207. 被引量:1
-
5连政,马依彤,杨毅宁,于子翔,李晓梅,王疆,陈铀,石文界.冠心病患者冠状动脉重构指数与血清LDL-C、 HDL-C相关性研究[J].中国心血管病研究,2015,13(9):787-791. 被引量:6
-
6杨有东,孟泽军,顾成圻.IVUS和FFR在冠状动脉临界病变治疗中的应用价值[J].中西医结合心脑血管病杂志,2016,14(9):1012-1014. 被引量:8
-
7毕雪峰.冠脉血管超声评价冠脉造影判断临界病变及斑块性质的准确性[J].中外医疗,2016,35(11):181-182. 被引量:3
-
8张东,张春鹏,刘顺顺,高迪,马春野.右冠状动脉起源于左冠状动脉前降支伴主动脉窦瘤破裂一例[J].中国心血管病研究,2017,15(2):190-192. 被引量:2
-
9孙耀林,赵骞.IVUS指导下介入治疗对冠状动脉临界病变FFR介于0.75~0.80患者预后的影响[J].心脏杂志,2018,30(6):683-686. 被引量:4
-
10白延平,徐凯,董海,荆全民,韩雅玲.血管内超声表现不同的冠状动脉斑块临床特点比较[J].中华老年多器官疾病杂志,2016,15(2). 被引量:5
同被引文献62
-
1Toth PP, Mccullough PA ,Wegner MS, et al. Lipoprotein-associ- ated phospholipase A2: role in arteriosclerosis and utility as a cardiovascular biomarker.Expert Rev Cardiovasc Ther,2010,8: 425-438.
-
2Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol,1983,51:606- 612.
-
3Chen YL , Bhasin A , Youssef AA, et al. Prognostic factors and outcomes in young chinese patients with acute myocardial infarc- tion undergoing primary coronary angioplasty. Int Heart J, 2009, 50:1-11.
-
4Knoflaeh M,Kiechl S,Penz D, et al. Cardiovascular risk factors and atherosclerosis in young women: athemsclerosis risk factors in female youngsters. Stroke, 2009,40:1063-1069.
-
5Chua SK, Hung HF, Shyu KG, et al. Acute ST-elevation myocar- dial infarction in young patients: 15 years of experience in a sin- gle center.Clin Cardiol, 2010,33:140-148.
-
6Vickers KC, Magui.re CT, Wolfert R, et al. Relationship of lipoprotein-assoeiated Phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis. J Lipid Res, 2009, 50: 1735-1743.
-
7Jinbo L,Rui C,Gopal K, et al. Circulating plateletactivating factor is primarily cleared by transport,not intravascular hy- drolysis by lipoprotein -associated phospholipase A2/PAF acetylhydrolase. Circ Res, 2011,108: 469-477.
-
8Erqou S, Kaptoge S, Perry PL, et al.Lipoprotein (a) concen- tration and the risk of coronary heart disease,stroke, and nonvascular mortality. JAMA,2009,302: 412-423.
-
9Tsimikas S,Mallat Z,Talmud PJ, et al.Oxidation-specific biomarkers,lipoprotein (a),and risk of fatal and nonfatal coro- nary events.Am Coil Cardiol, 2010, 56: 946-955.
-
10Packard CJ. Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target. Curr Opin Cardio1,2009,24: 358-363.
引证文献5
-
1邬真力,冉玉红,高迎春,张素英,董淑敏,贺雅男,袁金霞,曹文军.青年人急性心肌梗死与血浆脂蛋白相关磷脂酶A2水平的相关性研究[J].中国心血管病研究,2013,11(9):715-718. 被引量:9
-
2田希存,李春志,任华,于晓晶.冠状动脉易损斑块MSCTA影像特征分析[J].中国心血管病研究,2015,13(8):735-737. 被引量:2
-
3郑冠群,盛晓东,周建龙,范韬,金骁琦.原发性高血压患者颈动脉内膜中层厚度与脂蛋白相关磷脂酶A2水平相关性研究[J].中国心血管病研究,2015,13(10):909-912. 被引量:6
-
4陈月婷,张振,李卫娜.分泌性磷脂酶A2在STEMI再灌注损伤及愈后中的预测价值[J].西南国防医药,2016,26(9):963-966. 被引量:1
-
5董晓云,李荔,季青,赵彬.超微血管成像技术评价缺血性脑卒中患者颈动脉粥样硬化斑块内新生血管形成情况及其相关危险因素分析[J].中国医药,2017,12(6):869-872. 被引量:7
二级引证文献25
-
1张玉杰,樊瑛.妊娠相关血浆蛋白A与冠心病相关性的研究进展[J].中国心血管病研究,2019,17(1):13-16. 被引量:3
-
2李锦元.清化法治疗冠心病支架植入术后再狭窄临床研究[J].内蒙古中医药,2016,35(1):14-15. 被引量:1
-
3邬真力,孟军军,苏郑刚,杜晶,吴燕,苏鲁德夫,史萌萌,杨贞.青年不稳定型心绞痛患者冠脉病变与血浆脂蛋白相关磷脂酶A2的关系[J].中国心血管病研究,2016,14(5):420-423. 被引量:1
-
4陈月婷,张振,李卫娜,王国龙.分泌性磷脂酶A2在急性心肌梗死诊断中的应用[J].中国实验诊断学,2016,20(6):906-908. 被引量:2
-
5马国杰.彩色多普勒超声对原发性高血压颈动脉粥样硬化的诊断价值[J].中国实用医刊,2017,44(3):98-100. 被引量:5
-
6熊珍贵,沈云峰.2型糖尿病合并高血压患者昼夜血压波动与颈动脉内中膜厚度的相关性研究[J].实用糖尿病杂志,2017,13(1):42-43. 被引量:3
-
7何远文.原发性高血压患者伴发颈动脉粥样硬化病变与脂蛋白相关磷脂酶A2的临床意义表达[J].齐齐哈尔医学院学报,2017,38(5):571-572. 被引量:2
-
8梁春艳,温浩茂,谭淑英,王运林.2型糖尿病脂蛋白相关磷脂酶A2水平与颈动脉内膜中层厚度的关系[J].实用临床医学(江西),2017,18(7):1-3. 被引量:4
-
9齐杰.颈动脉内中膜厚度与血管炎性因子的相关性分析[J].中国药物与临床,2017,17(12):1811-1812. 被引量:8
-
10冯月平,袁炜华,邓婷.血浆脂蛋白相关磷脂酶A2检测在不稳定型心绞痛的应用价值[J].中国实用医药,2018,13(14):54-56.
-
1陆宗良.合理积极的调脂治疗[J].中华老年医学杂志,2006,25(3):223-223.
-
2孟娟娟.血管内皮细胞功能与动脉粥样硬化的研究进展[J].价值工程,2014,33(15):295-296. 被引量:2
-
3宋威,陈凤英.冠状动脉慢血流现象的研究进展[J].内蒙古医学杂志,2012,44(3):332-334. 被引量:1
-
4曹艳平.乙型肝炎患者为什么必须检查HBV-DNA?[J].肝博士,2017,0(1):43-43.
-
5伍铭艳.血液透析联合血液灌流治疗有机磷中毒的疗效分析[J].中国卫生产业,2013,10(15):162-163. 被引量:1
-
6郭利可,韩凌.代谢综合征综诊疗进展[J].临床和实验医学杂志,2014,13(5):414-418. 被引量:9
-
7俞菊英.生活干预对消化性溃疡愈合的影响[J].实用中西医结合临床,2005,5(4):67-67.
-
8王良平.卡维地洛对急性心肌梗死QT离散度影响[J].医药论坛杂志,2005,26(20):61-61.
-
9丛洪良.炎症细胞在动脉粥样硬化初期的作用[J].天津医药,2005,33(10):676-678. 被引量:3
-
10赵建江,章浩平.126例超声诊断脂肪肝患者血生化指标分析[J].浙江中西医结合杂志,2016,26(1):45-47. 被引量:5